Johnson & Johnson (JNJ) risk factors: FY2025 10-K

1. The Company’s businesses operate in highly competitive product markets and competitive pressures could adversely affect the Company’s earnings.
2. Interruptions and delays in manufacturing operations could adversely affect the Company’s business, sales and reputation.
3. The Company relies on third parties to manufacture and supply certain of our products. Any failure by or loss of a third-party manufacturer or supplier could result in delays and increased costs, which may adversely affect our business.
4. Counterfeit versions of our products could harm our patients and have a negative impact on our revenues, earnings, reputation and business.
5. Global health crises, pandemics, epidemics, or other outbreaks could adversely disrupt or impact certain aspects of the Company’s business, results of operations and financial condition.

Read these in Item 1A · See the changes

1. Global sales in the Company’s Innovative Medicine and MedTech segments may be negatively impacted by healthcare reforms and increasing pricing pressures.
2. The Company is subject to an increasing number of costly and complex governmental regulations in the countries in which operations are conducted which may have a material adverse affect on the Company’s financial condition and business operations.reworded
3. The Company is subject to significant legal proceedings that can result in significant expenses, fines and reputational damage.
4. Product reliability, safety and effectiveness concerns can have significant negative impacts on sales and results of operations, lead to litigation and cause reputational damage.
5. The Company faces significant regulatory scrutiny, which imposes significant compliance costs and exposes the Company to government investigations, legal actions and penalties.
6. Changes in tax laws or exposures to additional tax liabilities could negatively impact the Company’s operating results.

Read these in Item 1A · See the changes

1. The Company faces increased challenges to intellectual property rights central to its business.

Read these in Item 1A · See the changes

1. Significant challenges or delays in the Company’s innovation, development and implementation of new products, technologies and indications could have an adverse impact on the Company’s long-term success.

Read these in Item 1A · See the changes

1. The Company faces a variety of financial, economic, legal, social and political risks associated with conducting business internationally.
2. Due to the international nature of the Company's business, geopolitical or economic changes or events, including global tensions and war, could adversely affect our business, results of operations or financial condition.
3. Weak financial performance, failure to maintain a satisfactory credit rating or disruptions in the financial markets could adversely affect our liquidity, capital position, borrowing costs and access to capital markets.

Read these in Item 1A · See the changes

1. The planned separation of the Company's Orthopaedics business may not be completed on the terms or timeline currently contemplated, if at all, and may not achieve the expected resultsnew
2. The costs to complete the planned separation will be significant. In addition, the Company may be unable to achieve some of the strategic and financial benefits that it expects to achieve from the planned separation of the Company's Orthopaedics businessnew
3. Following the planned separation, the price of shares of the Company's common stock may fluctuate significantlynew
4. Our business depends on our ability to recruit and retain talented and highly skilled employees.
5. Climate change or legal, regulatory or market measures to address climate change may negatively affect our business and results of operations.
6. An information security incident, including a cybersecurity breach, could have a negative impact on the Company’s business or reputation.Cybersecurity
7. A breach of privacy laws or unauthorized access, loss or misuse of personal data could have a negative impact on the Company’s business or reputation.

Read these in Item 1A · See the changes